Stem Cell Storage, Simplified

The umbilical cord tissue contains important growth factors, cytokines, and mesenchymal stem cells (MSCs). These cord-derived MSCs are being studied in 100’s of clinical trials for illnesses such as autism, arthritis, diabetes, liver cirrhosis, and multiple sclerosis. There are also many new clinical surgical applications for cryopreserved umbilical cord tissue containing cells.

Some blood banks focus only on the MSCs and pre-process them prior to cryopreservation, limiting future treatment options. Americord’s CryoMaxx™ processing method unlocks the full potential of umbilical cord tissue by preserving the tissue’s inherent multipotent cells, growth factors, and cytokines. This method creates a versatile tissue for future use and gives families the flexibility of using the cord-derived MSCs for therapeutic applications or cord tissue containing MSCs for surgical applications for your baby, siblings, parents, and grandparents.

Americord’s unique proprietary CryoMaxx™ processing method uses a minimal manipulation method to isolate the amnion and chorion layers of the placental tissue and retain their inherent multipotent cells, growth factors, and cytokines.

The amnion and chorion are cryopreserved and stored in multiple vials, ensuring the potential for multiple uses for your baby, siblings, parents, or grandparents. This processing method creates a versatile tissue and gives families the flexibility to use therapeutic, wound, and ocular applications. And the potential is even more exciting than the current uses. These stem cells are in trials to establish new treatments for conditions cancers, organ failure, heart conditions, neurological dysfunction, and injuries to joints and the spine.